Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi

Summary. Aim: To investigate the use of PRESAGE 3D dosimeters to quantify the dosimetric variation between the static and dynamic conditions of three stereotactic ablative body radiotherapy techniques. Materials and Methods: An in-house custom-designed thorax dynamic phantom was designed to simulate...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2023
Автори: Tajaldeen, A., Alghamdi, S.
Формат: Стаття
Мова:English
Опубліковано: PH Akademperiodyka 2023
Теми:
Онлайн доступ:https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-11
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Experimental Oncology

Репозитарії

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-252
record_format ojs
institution Experimental Oncology
baseUrl_str
datestamp_date 2023-10-11T16:41:24Z
collection OJS
language English
topic 3D conformal radiotherapy (3D CRT)
intensity-modulated radiation therapy (IMRT)
PRESAGE 3D dosimeter
stereotactic ablative body radiotherapy (SABR)
volumetric modulated arc therapy (VMAT)
spellingShingle 3D conformal radiotherapy (3D CRT)
intensity-modulated radiation therapy (IMRT)
PRESAGE 3D dosimeter
stereotactic ablative body radiotherapy (SABR)
volumetric modulated arc therapy (VMAT)
Tajaldeen, A.
Alghamdi, S.
Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
topic_facet 3D conformal radiotherapy (3D CRT)
intensity-modulated radiation therapy (IMRT)
PRESAGE 3D dosimeter
stereotactic ablative body radiotherapy (SABR)
volumetric modulated arc therapy (VMAT)
3D conformal radiotherapy (3D CRT)
intensity-modulated radiation therapy (IMRT)
PRESAGE 3D dosimeter
stereotactic ablative body radiotherapy (SABR)
volumetric modulated arc therapy (VMAT)
format Article
author Tajaldeen, A.
Alghamdi, S.
author_facet Tajaldeen, A.
Alghamdi, S.
author_sort Tajaldeen, A.
title Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
title_short Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
title_full Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
title_fullStr Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
title_full_unstemmed Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
title_sort investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3d conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
title_alt Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi
description Summary. Aim: To investigate the use of PRESAGE 3D dosimeters to quantify the dosimetric variation between the static and dynamic conditions of three stereotactic ablative body radiotherapy techniques. Materials and Methods: An in-house custom-designed thorax dynamic phantom was designed to simulate the tumor motion in two directions (i.e., superior/inferior (Z-axis) and anterior/posterior (Y-axis)). The PRESAGE dosimeter was attached to the moving arm of the phantom and irradiated in two scenarios (static and dynamic) using three stereotactic ablative body radiotherapy (SABR) techniques: 3D conformal radiotherapy (3D CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT). Results: The highest differences in the mean volume measurements between the two conditions were noticed in IMRT (0.14 cm3) and 3D CRT (0.13 cm3). The mean volume measurements of the VMAT showed the lowest difference between the static and dynamic conditions of 0.10 cm3. The gamma analysis for 3%, 3-mm criterion showed passing rates of < 1 for 3D CRT, IMRT, and VMAT. Conclusion: This study quantify the dosimetric variations which are caused by the tumor motion in lung cases. In the SABR of the lung for QA purposes, this could help in identifying the prescription dose coverage due to tumor movement and correlate with the planned dose using 3D dosimeters like PRESAGE.
publisher PH Akademperiodyka
publishDate 2023
url https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-11
work_keys_str_mv AT tajaldeena investigationofdosimetricimpactoforganmotioninstaticanddynamicconditionsforthreestereotacticablativebodyradiotherapytechniques3dconformalradiotherapyintensitymodulatedradiationtherapyandvolumetricmodulatedarctherapybyusi
AT alghamdis investigationofdosimetricimpactoforganmotioninstaticanddynamicconditionsforthreestereotacticablativebodyradiotherapytechniques3dconformalradiotherapyintensitymodulatedradiationtherapyandvolumetricmodulatedarctherapybyusi
first_indexed 2025-07-17T12:17:04Z
last_indexed 2025-07-17T12:17:04Z
_version_ 1837896433894686720
spelling oai:ojs2.ex.aqua-time.com.ua:article-2522023-10-11T16:41:24Z Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi Tajaldeen, A. Alghamdi, S. 3D conformal radiotherapy (3D CRT), intensity-modulated radiation therapy (IMRT), PRESAGE 3D dosimeter, stereotactic ablative body radiotherapy (SABR), volumetric modulated arc therapy (VMAT) 3D conformal radiotherapy (3D CRT), intensity-modulated radiation therapy (IMRT), PRESAGE 3D dosimeter, stereotactic ablative body radiotherapy (SABR), volumetric modulated arc therapy (VMAT) Summary. Aim: To investigate the use of PRESAGE 3D dosimeters to quantify the dosimetric variation between the static and dynamic conditions of three stereotactic ablative body radiotherapy techniques. Materials and Methods: An in-house custom-designed thorax dynamic phantom was designed to simulate the tumor motion in two directions (i.e., superior/inferior (Z-axis) and anterior/posterior (Y-axis)). The PRESAGE dosimeter was attached to the moving arm of the phantom and irradiated in two scenarios (static and dynamic) using three stereotactic ablative body radiotherapy (SABR) techniques: 3D conformal radiotherapy (3D CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT). Results: The highest differences in the mean volume measurements between the two conditions were noticed in IMRT (0.14 cm3) and 3D CRT (0.13 cm3). The mean volume measurements of the VMAT showed the lowest difference between the static and dynamic conditions of 0.10 cm3. The gamma analysis for 3%, 3-mm criterion showed passing rates of < 1 for 3D CRT, IMRT, and VMAT. Conclusion: This study quantify the dosimetric variations which are caused by the tumor motion in lung cases. In the SABR of the lung for QA purposes, this could help in identifying the prescription dose coverage due to tumor movement and correlate with the planned dose using 3D dosimeters like PRESAGE. Summary. Aim: To investigate the use of PRESAGE 3D dosimeters to quantify the dosimetric variation between the static and dynamic conditions of three stereotactic ablative body radiotherapy techniques. Materials and Methods: An in-house custom-designed thorax dynamic phantom was designed to simulate the tumor motion in two directions (i.e., superior/inferior (Z-axis) and anterior/posterior (Y-axis)). The PRESAGE dosimeter was attached to the moving arm of the phantom and irradiated in two scenarios (static and dynamic) using three stereotactic ablative body radiotherapy (SABR) techniques: 3D conformal radiotherapy (3D CRT), intensity-modulated radiation therapy (IMRT), and volumetric modulated arc therapy (VMAT). Results: The highest differences in the mean volume measurements between the two conditions were noticed in IMRT (0.14 cm3) and 3D CRT (0.13 cm3). The mean volume measurements of the VMAT showed the lowest difference between the static and dynamic conditions of 0.10 cm3. The gamma analysis for 3%, 3-mm criterion showed passing rates of < 1 for 3D CRT, IMRT, and VMAT. Conclusion: This study quantify the dosimetric variations which are caused by the tumor motion in lung cases. In the SABR of the lung for QA purposes, this could help in identifying the prescription dose coverage due to tumor movement and correlate with the planned dose using 3D dosimeters like PRESAGE. PH Akademperiodyka 2023-06-05 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-11 10.32471/exp-oncology.2312-8852.vol-41-no-2.13164 Experimental Oncology; Vol. 41 No. 2 (2019): Experimental Oncology; 153-159 Експериментальна онкологія; Том 41 № 2 (2019): Експериментальна онкологія; 153-159 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-41-no-2 en https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-11/2019-2-11 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/